key: cord-1022396-jmdrupds authors: Hibino, S.; Hayashida, K.; Ahn, A. C.; Hayashida, Y. title: Dynamic Change of COVID-19 Seroprevalence among Asymptomatic Population in Tokyo during the Second Wave date: 2020-09-23 journal: nan DOI: 10.1101/2020.09.21.20198796 sha: 686cbc706b9b5dc064a1bbcba3b19e21925c9a9c doc_id: 1022396 cord_uid: jmdrupds Importance: Fatality rates related to COVID-19 in Japan have been low compared to Western Countries and have decreased despite the absence of lockdown. Serological tests monitored across the course of the second wave can provide insights into the population-level prevalence and dynamic patterns of COVID-19 infection. Objective: To assess changes in COVID-19 seroprevalence among asymptomatic employees working in Tokyo during the second wave. Design: We conducted an observational cohort study. Healthy volunteers working for a Japanese company in Tokyo were enrolled from disparate locations to determine seropositivity against COVID19 from May 26 to August 25, 2020. COVID-19 IgM and IgG antibodies were determined by a rapid COVID19 IgM/IgG test kit using fingertip blood. Across the company, tests were performed and acquired weekly. For each participant, serology tests were offered twice, separated by approximately a month, to provide self-reference of test results and to assess for seroconversion and seroreversion. Setting: Workplace setting within a large company. Participants: Healthy volunteers from 1877 employees of a large Japanese company were recruited to the study from 11 disparate locations across Tokyo. Participants having fever, cough, or shortness of breath at the time of testing were excluded. Main Outcome(s) and Measure(s): Seropositivity rate (SPR) was calculated by pooled data from each two-weeks window across the cohort. Either IgM or IgG positivity was defined as seropositive. Changes in immunological status against SARS-CoV-2 were determined by comparing results between two tests obtained from the same individual. Results: Six hundred fifteen healthy volunteers (mean + SD 40.8 + 10.0; range 19-69; 45.7 % female) received at least one test. Seroprevalence increased from 5.8 % to 46.8 % over the course of the summer. The most dramatic increase in SPR occurred in late June and early July, paralleling the rise in daily confirmed cases within Tokyo, which peaked on August 4. Out of the 350 individuals (mean + SD 42.5 + 10.0; range 19-69; 46.0 % female) who completed both offered tests, 21.4 % of those individuals who tested seronegative became seropositive and seroreversion was found in 12.2 % of initially seropositive participants. 81.1% of IgM positive cases at first testing became IgM negative in approximately one month. Conclusions and Relevance: COVID-19 infection may have spread widely across the general population of Tokyo despite the very low fatality rate. Given the temporal correlation between the rise in seropositivity and the decrease in reported COVID-19 cases that occurred without a shut-down, herd immunity may be implicated. Sequential testing for serological response against COVID-19 is useful for understanding the dynamics of COVID-19 infection at the population-level. Mortality from COVID-19 has been low in Japan as compared to the United States and European countries 1 . The reasons for the low number of deaths are unknown and may relate to either low prevalence of SARS-CoV-2 infections in the general population or diminished fatality rates among those infected. Distinguishing which of these factors come into play requires data on the total prevalence of SARS-CoV-2, particularly among the asymptomatic general population. To estimate the incidence of COVID-19, serology tests were obtained in asymptomatic individuals throughout the summer of the year 2020, incorporating the time before, during, and after the well-documented "secondwave" of COVID-19 infection in Japan. For each participant, serology tests were offered twice, separated by approximately a month, to provide self-references of test results, to identify cases of both seroconversion and seroreversion, and to estimate the seroprevalence of the general population in Tokyo over time. Six hundred fifteen healthy volunteers (mean + SD 40.8 + 10.0, range 19 -69; 45.7 % female) from 1877 employees of a large Japanese company were enrolled from 11 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. An outside ethical committee reviewed and approved the protocol. The demographic characteristics of participants were composited every two weeks and summarized in Table 1 . Seroprevalence increased from 5.8 % to 46.8 % throughout the summer (Figure) . The most dramatic increase in SPR occurred in late June and early July, paralleling the rise in daily confirmed cases within Tokyo 1, which peaked on August 4. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In this cohort, the SPR increased to an unexpectedly high 46.8 % by the end of the summer after the peak of the second-wave. This rate exceeds the estimated seroprevalence of COVID-19 in a known epicenter like New York City (20.2 %) 2 . Although our cohort was not selected from a broader, random sampling of Tokyo, this data may still be generalizable to the greater metropolitan area for a number of reasons: participants were sampled from multiple disparate locations across Tokyo; they had limited physical interactions with each other given the organizational structure of the . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.21.20198796 doi: medRxiv preprint company -limiting the role of clustering; participants were well-distributed across age and gender; and the initial SPR for this cohort started low at 5.9 % (95%CI [0,12.3%]) mirroring the pattern seen in Tokyo. Moreover, the exclusion of individuals with clinical symptoms may have led to an underestimation of total SPR. A high seropositivity rate in Tokyo may not be fully unexpected given its remarkably high population density, tightspacing, the widespread use of public transportation, and no implementation of a "lockdown". This study is unique in its utilization of sequential serological testing in a moderately sized cohort of asymptomatic individuals. The paired testing allows for an understanding of the temporal dynamics of the immunoglobulin response. First, the rapid tests did not yield any unreasonable answers: there were no illogical transitions (e.g., IgM-/IgG+ to IgM+/IgG-), and the overall SPR pattern remained stable over the course of testing ( Figure) . Second, IgM positivity is short-lived, typically turning negative over one month. Third, seroreversion was not infrequent, seen in 12% of participants over the one-month span between tests. This suggests that serological testing may significantly underestimate past COVID-19 infections, particularly when applied to an asymptomatic population. These findings should also take into context the epidemiological dynamics seen during this COVID-19 wave. Japan took the atypical step of not instituting a mandatory lockdown. During this time, businesses, restaurants, and transportation were kept open, and public life continued relatively unabated. Nevertheless, the second wave peaked . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This study has several limitations. First, the cohort was a sampling of a single large company in Tokyo and not of the population, in general. Second, detailed medical histories and behavioral patterns of each employee were not obtained. Such information would have been helpful in understanding the role of cross-exposure and the factors associated with reduced fatality. Third, paired testing was separated by a month. Closer intervals may have yielded more granular insights into the immunological responses to SARS-CoV-2 infection. Despite these limitations, this study is one of the first, to our knowledge, to obtain sequential COVID-19 serological testing in an . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.21.20198796 doi: medRxiv preprint Tests were performed at 5/26, 6/9, 6/16, 6/23, 6/30, 7/7, 7/14, 7/21,7/28, . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted September 23, 2020. . https://doi.org/10.1101/2020.09.21.20198796 doi: medRxiv preprint Coronavirus: Japan's mysteriously low virus death rate Updates on COVID-19 in Tokyo Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York Serology-informed estimates of SARS-CoV-2 infection fatality risk in